
MoCRA: Updates to FDA Safety Substantiation Requirements

Last year, a St. Louis city jury sent shock waves across the world, awarding 22 plaintiffs nearly $5 billion in compensatory and punitive damages in a lawsuit against Johnson & Johnson over claims its asbestos-contaminated talcum powder caused ovarian cancer in women who used the company’s product for years in the case of Ingham v. Johnson & Johnson, No. 1522-CC10417 (Mo. Cir. Ct. St. Louis City July 12, 2018). Prior to trial, Imerys Talc America Inc., a co-defendant supplier of talc to Johnson & Johnson, settled plaintiffs’ claims for at least $5 million.[1]
While previous ovarian cancer trials hinged on arguments that talc itself is carcinogenic, plaintiffs in Ingham argued their cancer was caused by asbestos particles mixed in with the talc. The impact of this verdict and similar previous decisions across the country has been damaging enough to prompt talc supplier Imerys Talc America Inc., to file for Chapter 11 bankruptcy, citing a lack of financial clout to defend lawsuits alleging that Imerys’ talc caused ovarian cancer or asbestos-related mesothelioma.[2]
The Illinois Supreme Court recently heard oral arguments in Jones v. Pneumo Abex LLC, Nos. 123895, 124002 cons. (Ill. 2019), where Plaintiffs, John and Deborah Jones, sued brake lining company Pneumo Abex (“Abex”) and glass bottle maker Owens-Illinois (“O-I”) for injuries John Jones allegedly suffered due to asbestos exposure during his construction career. Although Jones never worked for Defendants and never used or was exposed to any product of Defendants, Plaintiffs allege that Defendants entered into a civil conspiracy with the asbestos industry at large including Johns-Manville, an insulation and roofing materials manufacturer, to conceal the harmful health effects of asbestos exposure. In their complaint, Plaintiffs relied solely on circumstantial evidence to support their allegations of a conspiratorial agreement, including. (1) an Abex funded study on asbestos dust with Saranac Laboratory (the “Saranac report”) where a mice study revealing tumors was omitted from the published report; (2) a 1953 Sales Agreement between O-I and Owens Corning Fiberglas Corp. (“OCF”) for the sale of Kaylo insulation; (3) “non-toxic” ads that were issued by O-I and later by OCF; (4) O-I’s sharing of two asbestos health articles from 1941, (5) a unilaterally sponsored O-I study of Kaylo insulation involving exposure to lab animals; and (6) overlapping directors and stock ownership of O-I in OCF.
February 20, 2019 | Editor: Jen Dlugosz | Assistant Editor: Natalie Holden |
New Developments |
Missouri’s Game-Changing Opinion on Venue in Multi-Plaintiff Tort Litigation By Dominique Savinelli and Tim Larkin On February 13, 2019, the Supreme Court of Missouri dealt a significant blow against improper forum shopping by plaintiffs in mass tort litigation. The Johnson & Johnson |
…
On Monday, the Missouri Supreme Court issued an order sustaining Johnson & Johnson’s (“J&J”) last-minute Petition for writ of prohibition to stay the trial in Vickie Forrest et al. v. Johnson & Johnson et al., Cause No.1522-CC00419-01, pending in the in the Circuit Court of the City of St. Louis, Missouri. Although the Supreme Court sets forth no reasoning for the stay in its one paragraph en banc order, the trial, which was set to start on January 22, 2019, will not take place until the Court weighs in on J&J’s argument that conducting a single trial of multiple claims from multiple Plaintiffs – most of whom had potentially been improperly joined – is unfair to the defendants and even potentially in violation of J&J’s constitutional due process rights. State ex rel. Johnson & Johnson et al. v. The Honorable Rex M. Burlison, Cause No. SC97637. The Forrest case is one of an onslaught of talc cancer cases brought in the St. Louis City Circuit Court on behalf of multiple plaintiffs against J&J. Forrest, and twelve other women, are alleging that their different subtypes of ovarian or gynecological cancers were caused by their use of J&J’s talcum powder products, which allegedly contained asbestos.
December 18, 2018 | Editor: Jen Dlugosz | Assistant Editor: Natalie Holden |
New Developments |
This will be our final Toxic Tort Monitor for 2018. Thank you for continuing to subscribe to these updates. We wish you all happy holidays. Have a joyful new year! |
Cook County Jury Returns a Defense Verdict in Mesothelioma Trial |
…
November 12, 2018 | Editor: Jen Dlugosz | Assistant Editor: Natalie Holden |
New Developments |
Federal Court in Washington Holds Risks of Take-Home Asbestos Exposure Were Not Foreseeable Prior to 1955 By Paul Cranley In a recent decision of the U.S. District Court for the Western District of Washington, the court held that the dangers of |
…